Article · 1 Sep 2025
Short communicationPublished 2018
Allergen Immunotherapy: Current State and Ways Forward
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Allergen specific Immunotherapy (AIT), introduced more than one century ago, is the only allergen-oriented biological response modifier that redirects in a complex way the mode of response to antigens of the immune system. The traditional route of administration had remained for decades the subcutaneous one. In the last 30 years the sublingual administration was introduced and accepted. Nowadays, there are numerous large regulatory trials (mainly with sublingual tablets) confirming the efficacy and safety of this route for the more relevant allergens. The efficacy and safety of sublingual AIT was also consistently demonstrated in asthma, and the treatment is now included as possible adjunct in asthma guidelines. Obviously, a proper standardization of the products is mandatory. The component resolved diagnosis approach, allowed to better refine the prescription and the selection of candidate patients for AIT. In the next future, new administration routes are expected (epicutaneous, intralymphatic), together with the use of adjuvants. Also, the role of oral or sublingual desensitization for food allergy is currently emerging.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2013
Group-specific Multi-allergen Sublingual/Swallow Immunotherapy Improves the Quality of Life of Polysensitized Children and Adults with Allergic Rhinitis
Short communication · 23 Jul 2021
Sublingual Allergen Immunotherapy is Safe and Effective when Precisely Prescribed: The Three Decades of the Brazilian Experience
Research article · 2013
Clinical and Immunologic Effects of Allergen-Specific Sublingual Immunotherapy in a Canine Model of Atopic Dermatitis: A Double Blind, Randomized, Controlled Study
Perspective · 29 Sep 2023
Benefits of Allergen Immunotherapy and Safety Considerations
More from this journal
The newest in Journal of Allergy & Therapy.
Article · 29 Jun 2026
Allergy Diagnostics Innovation: Advancing Precision Identification of Immune Responses
Article · 29 Jun 2026
Immunomodulatory Therapeutics: Advancing Immune System Control Through Targeted Medical Strategies
Article · 29 Jun 2026
Immunoglobulin E (IgE) Regulation: Understanding Molecular Control of Allergic Immune Responses
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Allergy & Therapy
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Diego Bagnasco”
- BylineArticles whose byline prints “Matteo Ferrando”
- BylineArticles whose byline prints “Elisa Testino”
- BylineArticles whose byline prints “Annamaria Riccio”
- BylineArticles whose byline prints “Giorgio Walter Canonica”
- BylineArticles whose byline prints “Giovanni Passalacqua”

